SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity BioTech PLC ADR (TRIBY)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Eric Winterhalder who wrote (8)3/5/1997 9:25:00 AM
From: Henry Li   of 11
 
03/05 (DJ) Trinity Biotech Results -2: 4Q, Year Financial Table >TRIBY

Trinity Biotech plc - Dublin
4th Quar Dec. 31:
1996 1995
Revenues $2,088,000 $2,691,000
Net income (779,000) (359,000)
Avg shrs 16,963,770 13,538,676
Shr earns:
Net income (.05) (.03)
Year:
Revenues 7,152,000 9,908,000
Net income a (792,000) (831,000)
Avg shrs 16,119,559 11,135,753
Shr earns:
Net income a (.05) (.07)
Figures in parentheses are losses.
a. Includes a legal charge of $350,000 and an unrealized exchange
loss, since reversed, of $390,000. Excluding these items, the operating
net loss was $52,000.
Trinity Biotech plc (TRIBY) develops, manufactures and markets rapid
test for the clinical laboratory, point-of-care and over-the-counter
markets.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext